Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Nov 5;19(Suppl 1):56.
doi: 10.1186/s12893-019-0507-7.

Omentopexy With Glubran®2 for Reducing Complications After Laparoscopic Sleeve Gastrectomy: Results of a Randomized Controlled Study

Affiliations
Free PMC article
Randomized Controlled Trial

Omentopexy With Glubran®2 for Reducing Complications After Laparoscopic Sleeve Gastrectomy: Results of a Randomized Controlled Study

Vincenzo Pilone et al. BMC Surg. .
Free PMC article

Abstract

Background: Gastric fistulas, bleeding, and strictures are commonly reported after laparoscopic sleeve gastrectomy (LSG), that increase morbidity and hospital stay and may put the patient's life at risk. We report our prospective evaluation of application of synthetic sealant, a modified cyanoacrylate (Glubran®2), on suture rime, associated with omentopexy, to identify results on LSG-related complications.

Methods: Patients were enrolled for LSG by two Bariatric Centers, with high-level activity volume. Intraoperative recorded parameters were: operative time, estimated intraoperative bleeding, conversion rate. We prospectively evaluated the presence of early complications after LSG during the follow up period. Overall complications were analyzed. Perioperative data and weight loss were also evaluated. A control group was identified for the study.

Results: Group A (treated with omentopexy with Glubran®2) included 96 cases. Control group included 90 consecutive patients. There were no differences among group in terms of age, sex and Body Mass Index (BMI). No patient was lost to follow-up for both groups. Overall complication rate was significantly reduced in Group A. Mean operative time and estimated bleeding did not differ from control group. We observed three postoperative leaks in Group B, while no case in Group A (not statistical significancy). We did not observe any mortality, neither reoperation. Weight loss of the cohort was similar among groups. In our series, no leaks occurred applying omentopexy with Glubran®2.

Conclusion: Our experience of omentopexy with a modified cyanoacrylate sealant may lead to a standardized and reproducible approach that can be safeguard for long LSG-suture rime.

Trial registration: Retrospective registration on clinicaltrials.gov PRS, with TRN NCT03833232 (14/02/2019).

Keywords: Gastric fistula; Leak; Omentopexy; Sealant; Sleeve gastrectomy.

Conflict of interest statement

All authors declare that they have no conflict of interest, nor financial and non-financial competing interests related to study.

Figures

Fig. 1
Fig. 1
weight loss related to follow-up

Similar articles

See all similar articles

References

    1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2005;292(14):1724–1737. doi: 10.1001/jama.292.14.1724. - DOI - PubMed
    1. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–234. doi: 10.1111/joim.12012. - DOI - PubMed
    1. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8(8):CD003641. - PubMed
    1. Clinical IssuesCommittee of the AmericanSociety for Metabolic and Bariatric Surgery Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2010;6(1):1–5. doi: 10.1016/j.soard.2009.11.004. - DOI - PubMed
    1. van Rutte PW, Smulders JF, de Zoete JP, Nienhuijs SW. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J SurgMay. 2014;101(6):661–668. doi: 10.1002/bjs.9447. - DOI - PubMed

Publication types

Associated data

Feedback